本页面由Tiger Trade Technology Pte. Ltd.提供服务

Syros Pharmaceuticals, Inc.

0.0002
-0.0001-42.86%
成交量:1.21万
成交额:2.73
市值:5,366.49
市盈率:0.00
高:0.0005
开:0.0005
低:0.0002
收:0.0004
52周最高:0.0450
52周最低:0.0000
股本:2,683.25万
流通股本:2,391.73万
量比:2.75
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-3.0700
每股收益(LYR):-5.8100
净资产收益率:-776.96%
总资产收益率:-59.88%
市净率:-0.00
市盈率(LYR):0.00

数据加载中...

2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/05

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/02

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/31

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]